Home » Topics » Conferences

Conferences
RSS

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

Another beta3-adrenergic agent added to the BMS pipeline

Aug. 28, 1998

Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials

Aug. 28, 1998

News from the ACS: Roche synthesizes selective 5-HT2C antagonists

Aug. 28, 1998

Preclinical and clinical data reported for orbofiban, a potent antiplatelet agent

Aug. 28, 1998

ETA antagonism with LU-135252 may provide novel antiischemic therapy

Aug. 28, 1998

Contrast agent from Nycomed Imaging proves useful for several applications

Aug. 28, 1998

AR-C69931MX; a novel P2T antagonist with platelet aggregation-inhibitory activity

Aug. 28, 1998

Glaxo Wellcome presents development candidate GW-311616A

Aug. 27, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...